Publications
3 shownOsimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
In patients with stage IB to IIIA <i>EGFR</i> mutation-positive NSCLC, disease-free survival was significantly longer among those who received osimertinib than among those who r...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 3
- Citations
- 5,029
- Institution
- Evangelische Lungenklinik Berlin
External Links
Identifiers
- ORCID
- 0000-0003-2724-7647
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.